Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Current Value
$70.551 Year Return
Current Value
$70.551 Year Return
Market Cap
$41.40B
P/E Ratio
10.13
1Y Stock Return
4.84%
1Y Revenue Growth
0.92%
Dividend Yield
0.00%
Price to Book
4.3
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MXL | 48.90% | $1.22B | -18.18% | 0.00% |
F | 47.15% | $43.92B | +10.02% | 5.46% |
SYK | 43.87% | $148.17B | +32.36% | 0.82% |
BSX | 43.20% | $133.13B | +63.29% | 0.00% |
STM | 42.71% | $21.92B | -45.89% | 1.23% |
INVH | 42.07% | $20.85B | +2.62% | 3.32% |
LKQ | 39.61% | $9.77B | -17.44% | 3.20% |
WST | 39.05% | $22.02B | -13.73% | 0.27% |
ALGN | 38.32% | $16.62B | +3.38% | 0.00% |
TER | 38.15% | $16.74B | +12.03% | 0.46% |
WM | 36.94% | $87.92B | +27.58% | 1.34% |
ROL | 36.20% | $23.98B | +23.53% | 1.25% |
ITGR | 36.16% | $4.48B | +49.37% | 0.00% |
ISRG | 34.01% | $191.92B | +72.80% | 0.00% |
GTX | 33.26% | $1.66B | +4.72% | 0.00% |
KALU | 33.01% | $1.29B | +34.50% | 3.84% |
ASGN | 32.29% | $3.73B | -6.20% | 0.00% |
ORN | 32.16% | $333.77M | +78.01% | 0.00% |
RBBN | 31.72% | $678.74M | +86.06% | 0.00% |
RSG | 31.33% | $66.05B | +31.79% | 1.04% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
HTHT | -<0.01% | $11.34B | -0.47% | 0.00% |
SSL | -<0.01% | $3.28B | -56.07% | 2.00% |
TXT | 0.01% | $15.08B | +4.50% | 0.10% |
HAIN | -0.01% | $663.83M | -31.73% | 0.00% |
OPRT | 0.01% | $112.95M | +40.81% | 0.00% |
MSBI | 0.02% | $562.43M | +13.67% | 4.72% |
MED | -0.03% | $189.44M | -73.66% | 0.00% |
LGF.B | 0.03% | $1.63B | -25.36% | 0.00% |
PRO | 0.04% | $1.05B | -39.43% | 0.00% |
CATY | 0.04% | $3.63B | +39.53% | 2.69% |
KBR | -0.05% | $7.77B | +11.73% | 1.00% |
QD | -0.05% | $335.92M | +42.44% | 0.00% |
LNG | 0.06% | $49.37B | +24.99% | 0.82% |
RLI | 0.06% | $8.01B | +29.25% | 0.64% |
GL | 0.09% | $9.18B | -8.60% | 0.86% |
PFS | 0.10% | $2.58B | +37.31% | 4.62% |
HUBS | -0.10% | $35.23B | +44.73% | 0.00% |
CLAR | 0.10% | $163.42M | -17.76% | 2.35% |
JNJ | -0.11% | $368.37B | +1.24% | 3.18% |
MTRX | -0.11% | $358.21M | +30.13% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LTM | -75.88% | $8.51B | -100.00% | <0.01% |
POAI | -46.72% | $4.29M | -78.60% | 0.00% |
GSHD | -38.70% | $2.86B | +64.45% | 0.00% |
RES | -38.66% | $1.26B | -20.54% | 2.74% |
TCS | -35.87% | $14.81M | -84.46% | 0.00% |
NOC | -29.10% | $71.54B | +4.23% | 1.60% |
BALY | -28.65% | $726.31M | +54.50% | 0.00% |
RTX | -28.27% | $158.34B | +52.22% | 2.09% |
HNI | -27.54% | $2.62B | +39.78% | 2.40% |
MCRI | -27.01% | $1.52B | +28.67% | 1.45% |
OII | -26.16% | $2.78B | +32.07% | 0.00% |
LAZ | -24.02% | $4.81B | +106.38% | 3.64% |
NOW | -22.67% | $210.55B | +52.92% | 0.00% |
TYL | -21.65% | $25.67B | +45.89% | 0.00% |
MOH | -21.58% | $16.16B | -21.56% | 0.00% |
HP | -21.44% | $3.30B | -10.93% | 3.02% |
ACDC | -20.77% | $1.08B | -17.28% | 0.00% |
CLB | -20.37% | $929.61M | +8.55% | 0.20% |
SBSI | -20.35% | $1.07B | +25.26% | 4.11% |
PLXS | -20.01% | $4.30B | +48.90% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IHI | 50.77% | $4.91B | 0.4% |
XHE | 34.20% | $213.41M | 0.35% |
SPRE | 30.89% | $154.49M | 0.55% |
GSUS | 29.40% | $2.58B | 0.07% |
SCHX | 29.36% | $51.48B | 0.03% |
PBUS | 29.19% | $5.94B | 0.04% |
MILN | 29.17% | $126.77M | 0.5% |
DGRW | 28.86% | $14.87B | 0.28% |
RSPH | 28.78% | $885.96M | 0.4% |
VOTE | 28.75% | $713.10M | 0.05% |
PINK | 28.57% | $161.15M | 0.5% |
BBUS | 28.36% | $4.17B | 0.02% |
TSPA | 28.30% | $1.06B | 0.34% |
IWB | 28.30% | $38.73B | 0.15% |
NACP | 28.29% | $54.70M | 0.49% |
SPY | 28.22% | $627.39B | 0.0945% |
IVV | 28.22% | $552.84B | 0.03% |
FTQI | 28.22% | $492.22M | 0.75% |
GSLC | 28.20% | $13.36B | 0.09% |
CGGR | 28.18% | $8.53B | 0.39% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XHLF | -0.03% | $874.27M | 0.03% |
SEIX | 0.13% | $268.81M | 0.62% |
CMDY | -0.16% | $279.14M | 0.28% |
SMB | -0.19% | $266.77M | 0.07% |
BCD | -0.22% | $245.02M | 0.3% |
IBD | 0.26% | $330.68M | 0.44% |
TBIL | 0.27% | $4.38B | 0.15% |
CCOR | 0.37% | $109.04M | 1.18% |
IBDP | -0.40% | $2.11B | 0.1% |
SHYD | 0.42% | $311.50M | 0.35% |
BCI | -0.43% | $1.20B | 0.26% |
SPIP | 0.45% | $858.31M | 0.12% |
BOXX | -0.54% | $4.43B | 0.1949% |
ITA | 0.57% | $6.36B | 0.4% |
HYMB | -0.61% | $2.81B | 0.35% |
VTIP | 0.83% | $11.71B | 0.04% |
IBTF | 0.86% | $2.05B | 0.07% |
FXN | 0.89% | $416.11M | 0.62% |
GOVZ | 0.94% | $313.00M | 0.1% |
ICLO | -1.06% | $209.30M | 0.2% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TPMN | -22.19% | $40.60M | 0.65% |
SOYB | -17.86% | $27.32M | 0.22% |
BTAL | -15.38% | $388.04M | 1.43% |
VIXY | -14.37% | $195.31M | 0.85% |
DBO | -12.81% | $217.57M | 0.77% |
DBE | -12.42% | $50.13M | 0.77% |
TAIL | -12.07% | $67.98M | 0.59% |
PSCE | -11.65% | $91.62M | 0.29% |
XES | -11.46% | $208.58M | 0.35% |
COMT | -11.13% | $829.06M | 0.48% |
EQLS | -11.07% | $76.08M | 1% |
GSG | -11.01% | $914.42M | 0.75% |
OIH | -10.65% | $1.69B | 0.35% |
DBC | -10.55% | $1.39B | 0.87% |
USDU | -10.54% | $201.97M | 0.5% |
PDBC | -10.32% | $4.40B | 0.59% |
UUP | -8.35% | $309.25M | 0.77% |
FMF | -5.47% | $244.61M | 0.95% |
KMLM | -5.47% | $353.87M | 0.9% |
CANE | -5.35% | $17.72M | 0.29% |
Finnhub
NEW YORK, Nov. 21, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Edwards Lifesciences Corporation . ...
Yahoo
In November 2024, global markets experienced notable fluctuations as investors reacted to the incoming Trump administration's policy signals and Federal Reserve Chair Jerome Powell's comments on interest rates. The S&P 600 index, which tracks small-cap stocks, was influenced by these broader economic dynamics, showcasing a mix of opportunities and challenges for investors focusing on smaller companies. In this context, identifying promising small-cap stocks involves assessing those that...
Finnhub
NEW YORK, Nov. 19, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation of a class action securities lawsuit. ...
Finnhub
NEW YORK, Nov. 18, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation between February 6, 2024 and July...
MarketWatch
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day
Finnhub
LOS ANGELES, Nov. 18, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ...
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.